Pfizer-BioNTech seeks authorisation for 12-15 year olds in US According to the companies, their request to the U.S. Food and Drug Administration came after Phase 3 clinical trials of the vaccine in children
Pfizer-BioNTech seeks authorisation for 12-15 year olds in US According to the companies, their request to the U.S. Food and Drug Administration came after Phase 3 clinical trials of the vaccine in children
More3 years ago